On the basis of this, we hypothesized that alterations in DNA damage response (DDR) pathways before the development of cancer might also be responsible for other phenotypes accompanying BRCA1-associated breast cancers: namely rapid tumour onset, extensive genomic instability and the preferential loss of p53 and pRb. Here, TP53 is linked to breast cancer.